CDSCO issued a notification regarding the list of Drugs as Not of Standard Quality Alert for the Month of August – 2024

Sep 23, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe Central Drugs Standard Control Organisation (CDSCO) on September 20, 2024, issued a notification regarding the list of drugs that were stated as “Not of Standard Quality Alert for the Month of August – 2024”

• The list of Product/Drug Name along with the Batch No., Manufacturing Date, Expiry Date, NSQ Result have been stated.

• The following Drugs have been stated as Not of Standard Quality namely: -

o Amoxicillin And Potassium Clavulanate Tablets IP (Clavam 625) 

o Calcium And Vitamin D3 Tablets IP Shelcal 500 (Shelcal) 

o Metformin Hydrochloride Sustained-release Tablets IP (Glycimet-SR-500) 

o Vitamin B Complex with Vitamin C Softgels 

o Rifmin 550 (Rifaximin Tablets 550 mg) 

o Pantoprazole Gastro -Resistant and Domperidone Prolonged -Release Capsules IP (Pan - D)


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT